These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9881074)
1. Multimodal therapy in rectal cancer. Link KH; Staib L; Schatz M; Suhr P; Röttinger E; Beger HG Gan To Kagaku Ryoho; 1998 Dec; 25(14):2167-92. PubMed ID: 9881074 [TBL] [Abstract][Full Text] [Related]
2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495 [TBL] [Abstract][Full Text] [Related]
3. Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer. Link KH; Staib L; Kornmann M; Formentini A; Schatz M; Suhr P; Messer P; Röttinger E; Beger HG; Swiss Surg; 2001; 7(6):256-74. PubMed ID: 11771444 [TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
5. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. Cafiero F; Gipponi M; Lionetto R; J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681 [TBL] [Abstract][Full Text] [Related]
8. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment. Gunderson LL; Haddock MG; Schild SE Semin Radiat Oncol; 2003 Oct; 13(4):419-32. PubMed ID: 14586831 [TBL] [Abstract][Full Text] [Related]
10. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer]. Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150 [TBL] [Abstract][Full Text] [Related]
11. [Rectal cancer: current status of multimodal therapy--when and how?]. Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
13. [Advance in preoperative radiochemotherapy for resectable rectal cancer]. Chen YH; Li ZP Ai Zheng; 2008 Dec; 27(12):1341-4. PubMed ID: 19080006 [TBL] [Abstract][Full Text] [Related]
14. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. Bosset JF; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Briffaux A; Collette L J Clin Oncol; 2005 Aug; 23(24):5620-7. PubMed ID: 16009958 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of rectal cancer]. Rödel C; Bruch HP; Hofheinz R; Lang H; Arnold D Onkologie; 2010; 33 Suppl 4():19-23. PubMed ID: 20431308 [TBL] [Abstract][Full Text] [Related]
16. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844 [TBL] [Abstract][Full Text] [Related]
17. [The adjuvant therapy of rectal carcinoma: its current status]. Dunst J; Sauer R Strahlenther Onkol; 1994 Jul; 170(7):375-82. PubMed ID: 8052936 [TBL] [Abstract][Full Text] [Related]
18. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany). Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839 [TBL] [Abstract][Full Text] [Related]
19. Results of local excision followed by postoperative radiation therapy for rectal cancer. Minsky BD Radiat Oncol Investig; 1997; 5(5):246-51. PubMed ID: 9372547 [TBL] [Abstract][Full Text] [Related]